DMTK

DermTech, Inc. Common Stock
DMTK

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

DMTK was delisted on the 26th of June, 2024.

Back to rankings
 

About: DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

Employees: 208

Healthcare Diagnostics & Research
Price charts implemented using Lightweight Charts™